Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 409
Aptamer sequence: GTCTTGACTAGTTACGCCCCCAAGAACCCGCTTGCCGTGGTGACGTTGATCATGTCGTTTGGTCATTCAGTTGGCGCCTC
Target unique ID: P48551
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_403 IFNα-1 aptamer Protein INAR2_HUMAN 4.52 nM 10 mM Tris pH 7.5, 10 mM MgCl2, 50 mM KCl, 25 mM NaCl 33063508
Structure information of aptamer
Aptamer Sequence: GTCTTGACTAGTTACGCCCCCAAGAACCCGCTTGCCGTGGTGACGTTGATCATGTCGTTTGGTCATTCAGTTGGCGCCTC
The optimal secondary structure in dot-bracket notation: .(((((..............)))))....((..((((...(((...((((((.......)))))).)))..))))))...
The centroid secondary structure in dot-bracket notation: ..((((..............))))......................((((((.......))))))...............
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_403 Description IFNα-1 aptamer
Aptamer chemistry DNA Length 80 nt
GC content 55.0% Molecular weight 24,561.66 Da
Molarity of 1 μg/μl solution 40.71 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence GTCTTGACTAGTTACGCCCCCAAGAACCCGCTTGCCGTGGTGACGTTGATCATGTCGTTTGGTCATTCAGTTGGCGCCTC
Applications Designing of aptamers similar to the IFNα-3 aptamer provides a novel approach to assess other inflammatory protein(s) in patients before, during, and after completion of treatment and would denote clinical improvement in successfully treated patients
Target information
Type Detail Type Detail
Uniprot ID P48551 Protein name Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
Gene name(s) IFNAR2 IFNABR IFNARB Organism Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2)
Status reviewed in uniprot database Length 515
Mass 57,759 Activity regulation N/A
Involvement in disease Immunodeficiency 45 (IMD45) Catalytic activity N/A
PDB ID(s)
1N6U;1N6V;2HYM;2KZ1;2LAG;3S8W;3S9D;3SE3;3SE4;
Function Associates with IFNAR1 to form the plasma membrane receptor in the type I interferon signaling pathway.
Activity data
Interaction ID 409
Target type Protein
Target unique ID P48551
Activity 4.52 nM
Binding Conditions/Buffer

10 mM Tris pH 7.5, 10 mM MgCl2, 50 mM KCl, 25 mM NaCl

Assay

Binding affinity of selected aptamers. The dissociation constant (Kd) curve derived through nonlinear regression represents the binding affinity of (C) IFNα-1 and (D) IFNα-3 aptamers to 250 ng of the IFN-α protein

PubMed ID 33063508
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_404 DNA GTCTTGACTAGTTACGCCCACAAGAACCTGCTTGCCATGGTGACGCCGATCATGCTTTTTGGTCATTCAGTTGGCGCCTC
90.00%
Apta_738 DNA ATCGTCTGCTCCGTCCAATACCTGCATATACACTTTGCATGTGGTTTGGTGTGAGGTCGTGC 55.00%
Apta_1071 DNA TTGAAGTGACTCCGCACTGGGTGGGTGGGAGGGTCGTGCGGCTGGTCATAGCAGGGT 55.00%
Apta_1173 DNA TTGACTTGCCACTGACTACCCCAGTATCTCTTCAACGCTATGGTGCATGTACTACGTATTGAAGTCAGTCGGTCGTCATC 53.75%
Apta_627 DNA ATACCAGCTTATTCAATTATGCGGGGATGAGGCTTGATCTGTGGCTCTGATCCATGATCAGTCGTCTTACGTGCGGTCCAGATAGTAAGTGCAATCT 52.58%
Apta_804 DNA GCGGGATCCTATGACGCATTGACCCACAACACACTACTGTCGCTCGGTTCGAACTTCGTGCGACTGTTCCCTATAGTGAGTCGTATTAGAATTCCGC 52.58%
Apta_627 DNA ATACCAGCTTATTCAATTATGCGGGGATGAGGCTTGATCTGTGGCTCTGATCCATGATCAGTCGTCTTACGTGCGGTCCAGATAGTAAGTGCAATCT 52.58%
Apta_127 DNA GGTATTGAGGGTCGCATCCACTGGTCGTTGTTGTCTGTTGTCTGTTATGTTGTTTCGTGATGGCTCTAACTCTCCTCT 52.50%
Apta_570 DNA GGCAAGATGTGCCCAGAACAGTTGCTTGTATGGTGGGGAGCGTCCATATTGGCTTAAAC 52.50%
Apta_600 DNA GTCTCTGTGTGCGCCAGAGAACACTGGGGCAGATATGGGCCAGCACAGAATGAGGCCC 52.50%
Apta_653 DNA CCTGCACCTCGTCCAGCATCCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGGTG 52.50%
Apta_737 DNA ATCGTCTGCTCCGTCCAATAGTGCATTGAAACTTCTGCATCCTCGTTTGGTGTGAGGTCGTGC 52.50%
Apta_997 DNA ATAGGAGTCGACCGACCAGACCCCGCCTCTCCTTTTCATGTGACACAATGGTGCGTCTACATCTAGACTC 52.50%
Apta_1003 DNA ATAGGAGTCGACCGACCAGACCCCGCCTCTCCTTTCATGTGACACAATGGTGCGTCTACATCTAGACTC 52.50%
Apta_600 DNA GTCTCTGTGTGCGCCAGAGAACACTGGGGCAGATATGGGCCAGCACAGAATGAGGCCC 52.50%
Apta_281 DNA CCGTAATACGACTCACTATAGGGGAGCTCGGTACCGAATTCATGTTGGTAGTTGGCTTGTGTTCGTGTGTTAAGCTTTCAGAGAGGATCCTT 52.17%
Apta_704 DNA GTACGAATTCACGAGGTTGCCAGCGGGGCCAGCCACTTCTGTCAGTGAATTCCTGCTCGTATATCTACTCGCCCGCCTGCGAGCATGGAGTCGGATCCTCTA 51.96%
Apta_490 DNA GGGAGACAAGAATAAACGCTCAAGGGCGTGGTGGGTGGGGTACTAATAATGTGCGTTTGTTCGACAGGAGGCTCACAACAGGC 51.81%
Apta_1135 DNA GCCGAGATTGCACTTACTATCTCATCAATAAAGATTATAGGGTGAAGGTGATAGTAGGTGGTATATAGGGTAATTGAATAAGCTGGTATGCGC 51.61%
Apta_78 DNA ATCTCGACTAGTCATAGGGGGCGCGAACATACGCGGTTGGTGTGGTTGGCTGACAATACTCGT 51.25%